Eagle Global Advisors LLC Organon & Co. Transaction History

Eagle Global Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$21.42 - $32.08 $3,148 - $4,715	-147 Reduced 1.15%	12,682 $298,000
Q4 2022 Feb 07, 2023	SELL	$23.31 - $28.61 $9,650 - $11,844	-414 Reduced 3.13%	12,829 $358,000
Q3 2022 Oct 24, 2022	SELL	$23.4 - $34.25 $4,984 - $7,295	-213 Reduced 1.58%	13,243 $310,000
Q2 2022 Aug 11, 2022	SELL	$31.66 - $38.9 $11,049 - $13,576	-349 Reduced 2.53%	13,456 $454,000
Q1 2022 Apr 20, 2022	SELL	$30.45 - $39.36 $9,957 - $12,870	-327 Reduced 2.31%	13,805 $482,000
Q4 2021 Feb 01, 2022	SELL	$28.67 - $37.13 $26,720 - $34,605	-932 Reduced 6.19%	14,132 $430,000
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $30,662 - $38,170	-1,071 Reduced 6.64%	15,064 $494,000
Q2 2021 Jul 15, 2021	BUY	$28.45 - $38.0 $459,040 - $613,130	16,135 New	16,135 $488,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Eagle Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Eagle Global Advisors LLC with notifications on news.